AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 157 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,903,900 | -27.9% | 176,036 | -33.4% | 0.00% | -25.0% |
| Q2 2023 | $12,346,050 | +432.2% | 264,426 | +336.1% | 0.00% | +300.0% |
| Q1 2023 | $2,319,933 | +24.0% | 60,636 | +77.6% | 0.00% | 0.0% |
| Q4 2022 | $1,870,872 | +595.5% | 34,140 | +331.9% | 0.00% | – |
| Q3 2022 | $269,000 | +163.7% | 7,904 | -27.0% | 0.00% | – |
| Q2 2022 | $102,000 | -85.5% | 10,830 | -78.2% | 0.00% | – |
| Q1 2022 | $704,000 | -49.1% | 49,652 | -24.1% | 0.00% | – |
| Q4 2021 | $1,384,000 | +3.1% | 65,429 | +9.0% | 0.00% | – |
| Q3 2021 | $1,343,000 | +521.8% | 60,033 | +591.6% | 0.00% | – |
| Q2 2021 | $216,000 | -61.8% | 8,680 | -55.5% | 0.00% | – |
| Q1 2021 | $566,000 | – | 19,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |